Friedreich’s Ataxia News present a new study on a vibration device that could help movement coordination for ataxic persons

Resume from the Friedreich’s Ataxia News article, Vibration Device, Equistasi, Seen to Aid Movement in Ataxia Patients in Small Study  “The study, “A Wearable Proprioceptive Stabilizer For Rehabilitation Of Limb And Gait Ataxia In Hereditary Cerebellar Ataxias: A Pilot Open-Labeled Study,” was published in the journal Neurological Sciences. Equistasi is...

Continue reading

Santhera’s MICONOS Trial with Catena in Friedreich’s Ataxia Misses Primary Endpoint

Press Release Liestal, Switzerland, May 20, 2010 – Santhera Pharmaceuticals (SIX: SANN) announced today that its MICONOS Phase III study evaluating Catena®/Sovrima® for the treatment of Friedreich’s Ataxia missed its primary endpoint. Trends towards improvement in the key neurological endpoint were however identified by a meta-analysis of all Santhera’s Phase...

Continue reading

Health Canada Approves Catena® for Treatment of Friedreich’s Ataxia

News Release Liestal, Switzerland, July 24, 2008 – Santhera Pharmaceuticals (SWX:SANN), a Swiss specialty pharmaceutical company focused on neuromuscular diseases, announced today that Health Canada has approved with conditions SNT-MC17/idebenone for the treatment of Friedreich’s Ataxia. Health Canada’s decision is the first marketing authorization worldwide for any Friedreich’s Ataxia therapy....

Continue reading

Hearing Problems in Persons Afflicted with Friedreich’s Ataxia

In July 1999, Mrs. Nicole St-Jean of the Canadian Association of Friedreich’s Ataxia asked me for an article concerning hearing problems related to this disease. The presence of hearing problems in persons afflicted with Friedreich’s ataxia is misunderstood. One knows better the dominant symptoms leading to the diagnosis such as...

Continue reading